NF1 and neoplasm: Second, silencing NF1/Nf1 in doxorubicin‐treated SW1573 cells as well as doxorubicin‐treated LKR10 and LKR13 clones resulted in significantly greater subcutaneous tumor volumes across all three models (Fig 2J–L).